90
Participants
Start Date
October 31, 2006
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Fluvoxamine maleate
Test product: Fluvoxamine maleate 25mg tablet. In case that the daily dose is one tablet, the study medication will orally be administered once daily, at bedtime. In case that the daily dose is two tablets or higher (maximam:6 tablets), the study mmedica
Placebo
Placebo
S114.3.117 Kohnodai Hospital, National Center of N, Chiba Prefecture
S114.3.117 Fukuoka University Hospital, Fukuoka Prefecture
S114.3.117 Hatakeyama Clinic, Fukuoka Prefecture
S114.3.117 Kaname Clinic, Fukuoka Prefecture
S114.3.117 Kashi shinryo Clinic, Fukuoka Prefecture
S114.3.117 Kashii Sanatorium, Fukuoka Prefecture
S114.3.117 Kyushu University Hospital, Fukuoka Prefecture
S114.3.117 Shiranui Hospital, Fukuoka Prefecture
S114.3.117 Sugahara Tenjin Hospital, Fukuoka Prefecture
S114.3.117 Hiroshima-city Funairi Hospital, Hiroshima Prefecture
S114.3.117 Goryokai Hospital, Hokkaido Prefecture
S114.3.117 Kobe University Hospital, Hyogo Prefecture
S114.3.117 National Hospital Organization Kagawa C, Kagawa Prefecture
S114.3.117 Yokohama City University Hospital, Kanagawa Prefecture
S114.3.117 National Hospital Organization Kikuti N, Kumamoto Prefecture
S114.3.117 Kyoto University Hospital, Kyoto Prefecture
S114.3.117 National Hospital Organization Sakakiba, Mie Prefecuture
S114.3.117 Shinshu University Hospital, Nagano Prefecture
S114.3.117 Aichi Children's Health and Medical Cen, Nagoya Prefecture
S114.3.117 Nagoya Mental Clinic, Nagoya Prefecture
S114.3.117 Nara Medical University Hospital, Nara Prefecture
S114.3.117 Kansai Medical University Takii Hospita, Osaka Prefecture
S114.3.117 Kusube Clinic, Osaka Prefecture
S114.3.117 Yasuhara Children's Clinic, Osaka Prefecture
S114.3.117 Tokushima University Hospital, Tokushima Prefecture
Solvay Pharmaceuticals
INDUSTRY